← Browse by Condition
Medical Condition
central nervous system lymphoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1, Phase 2
NCT05260619 Phase 2
Recruiting
Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
Enrollment
28 pts
Location
South Korea
Sponsor
Seoul National University Bund...
NCT07416890 Phase 2
Recruiting
Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma
Enrollment
24 pts
Location
China
Sponsor
Zhejiang Cancer Hospital
NCT05698147 Phase 1, Phase 2
Recruiting
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Enrollment
30 pts
Location
China
Sponsor
Tong Chen, MD